Author/Authors :
Alavinejad, Elaheh Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Sajedi, Zahra Immunology Research Center - Tabriz University of Medical Sciences, Tabriz, Iran , Razipour, Masoumeh Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Entezam, Mona Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Mohajer, Neda Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Setoodeh, Aria Department of Pediatrics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Talebi, Saeed Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran , Keramatipour, Mohammad Department of Medical Genetics - Faculty of Medicine - Tehran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Phenylalanine hydroxylase (PAH) gene is the well-known causative
gene for classic Phenylketonuria (PKU) (OMIM#261600) disease, with more than 500
reported mutations. Through this study, a novel mutation in the PAH gene in an Iranian
pedigree with phenylketonuria was introduced.
Methods: A consanguineous family with a 10-year old affected girl was referred for
genetic analysis. Mutation screening of all exons and exon-intron boundaries was performed
by Sanger sequencing, and mini haplotype analysis was carried out by genotyping
of Short Tandem Repeat (STR) and Variable Number Tandem Repeat (VNTR)
alleles.
Results: Mutation analysis revealed a novel homozygous insertion of a single adenine
nucleotide at position 335 in exon 3 of the PAH gene. Based on the American College
of Medical Genetics and Genomics (ACMG) guidelines, the change is interpreted as a
pathogenic mutation which produces a premature termination signal (TAA) at codon
113 according to in silico assessments. The mini haplotype analysis showed that this mutation
was linked to STR (15) –VNTR (3).
Conclusion: In this study, a novel mutation was reported in a patient who had PKU
symptoms without any previously reported mutations in the PAH gene (NM_000277.1
:p.Asp112Glufs*2) that can be responsible for the classical PKU phenotype in the Iranian
population. Detection of novel mutations indicates notable allelic heterogeneity of
the PAH locus among this population.
Keywords :
Population , Phenylketonurias , Phenylalanine hydroxylase , Mutation